Adenocarcinoma of the lung: Clinicopathological study
Copyright policy )Adenocarcinoma of the lung: Clinicopathological study
AbstractA review of our 247 patients with adenocarcinoma of the lung revealed the overall five year survival rate to be only 0.81%.Lung resection offers the chance of cure if the lesion is peripherally located and without lymph node involvement. Direct chest wall invasion by tumor is not contraindication to surgery. Radiation therapy was not especially effective in our series. Several chemotherapeutic agents gave an overall response of 31.1%.
- State University of New York at Potsdam United States
- University at Buffalo, State University of New York United States
- New York State Department of Health United States
Adult, Male, Lung Neoplasms, Palliative Care, New York, Antineoplastic Agents, Adenocarcinoma, Middle Aged, Lymphatic Metastasis, Carcinoma, Squamous Cell, Humans, Female, Autopsy, Neoplasm Metastasis, Aged, Retrospective Studies
Adult, Male, Lung Neoplasms, Palliative Care, New York, Antineoplastic Agents, Adenocarcinoma, Middle Aged, Lymphatic Metastasis, Carcinoma, Squamous Cell, Humans, Female, Autopsy, Neoplasm Metastasis, Aged, Retrospective Studies
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).20 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!